Original Articles: Hormones and Reproductive Health
Double-Blind Y Chromosome Microdeletion Analysis in Men with Known Sperm Parameters and Reproductive Hormone Profiles: Microdeletions Are Specific for Spermatogenic Failure1
Csilla Krausz,
Ewa Rajpert-De Meyts,
Lone Frydelund-Larsen,
Lluis Quintana-Murci,
Ken McElreavey and
Niels E. Skakkebaek
Immunogénétique Humaine (C.K., L.Q.-M., K.M.), Institut
Pasteur, 75724 Paris Cedex 15 France; Unità di Andrologia (C.K.),
Dipartimento di Fisiopatologia Clinica, Viale Pieraccini, 6, 50139
Firenze, Italy; and University Department of Growth and Reproduction
(E.R.-D.M., L.F.-L., N.E.S.), Rigshospitalet, 9, Blegdamsvej, DK-2100
Copenhagen, Denmark
Address all correspondence and requests for reprints to: Ken McElreavey, Immunogénétique Humaine, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex 15, France. E-mail:
kenmce{at}pasteur.fr
Abstract
Y chromosome microdeletions have been reported as a possiblegenetic
factor of male infertility. Despite a large number ofstudies in this
subject, there is still considerable debateand confusion surrounding
the role of Y chromosome microdeletionsin male infertility. This has
been further compounded by observationsof Y microdeletions in fertile
males. The aim of the presentstudy was to evaluate: 1) the incidence
of Y microdeletionsin control male population and infertile males,
where completesemen and hormonal analysis was available to define
whetherY microdeletions are specific for spermatogenic failure or if
theycan be found also in normospermic men; and 2) whether the
suboptimalsemen quality reported in Denmark is associated with a
higherincidence of Y microdeletions in respect to other populations.
Double-blindmolecular study of deletions was performed in 138
consecutivepatients seeking intracytoplasmic sperm injection
treatment,100 men of known fertility, and 107 young military
conscriptsfrom the general Danish population. Microdeletions or
gene-specificdeletions were not detected in normospermic subjects or
in subfertilemen with a sperm count of more than 1 x
106/mL. Deletions ofthe Azoospermia factor (AZF)c region
were detected in 17% ofindividuals with idiopathic
azoo/cryptozoospermia and in 7%of individuals with nonidiopathic
azoo/cryptozoospermia. Thedata indicate that: 1) the composition of
the study populationis the major factor in determining deletion
frequency; 2) Ychromosome microdeletions are specifically associated
with severespermatogenic failure; therefore, the protocol described
hereis reliable for the routine clinical workup of severe male factor
infertility;and 3) the frequency of Yq microdeletions in the
Danish populationis similar to that from other countries and argues
against theinvolvement of microdeletions in the relatively low sperm
countof the Danish population.
This article has been cited by other articles:
C. Mau Kai, A. Juul, K. McElreavey, A.M. Ottesen, I.D. Garn, K.M. Main, A. Loft, N. Jorgensen, N.E. Skakkebaek, A. N. Andersen, et al. Sons conceived by assisted reproduction techniques inherit deletions in the azoospermia factor (AZF) region of the Y chromosome and the DAZ gene copy number
Hum. Reprod.,
July 1, 2008;
23(7):
1669 - 1678.
[Abstract][Full Text][PDF]
E. Rajpert-De Meyts Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects
Hum. Reprod. Update,
May 1, 2006;
12(3):
303 - 323.
[Abstract][Full Text][PDF]
G. Vinci, F. Raicu, L. Popa, O. Popa, R. Cocos, and K. McElreavey A deletion of a novel heat shock gene on the Y chromosome associated with azoospermia
Mol. Hum. Reprod.,
April 1, 2005;
11(4):
295 - 298.
[Abstract][Full Text][PDF]
C. Krausz, E. Guarducci, L. Becherini, S. degl'Innocenti, L. Gerace, G. Balercia, and G. Forti The Clinical Significance of the POLG Gene Polymorphism in Male Infertility
J. Clin. Endocrinol. Metab.,
September 1, 2004;
89(9):
4292 - 4297.
[Abstract][Full Text][PDF]
M. Joffe Infertility and environmental pollutants
Br. Med. Bull.,
December 1, 2003;
68(1):
47 - 70.
[Abstract][Full Text][PDF]
L. Frydelund-Larsen, P. H. Vogt, H. Leffers, A. Schadwinkel, G. Daugaard, N. E. Skakkebaek, and E. Rajpert-De Meyts No AZF deletion in 160 patients with testicular germ cell neoplasia
Mol. Hum. Reprod.,
September 1, 2003;
9(9):
517 - 521.
[Abstract][Full Text][PDF]
J. J. Kurinczuk Safety issues in assisted reproduction technology: From theory to reality--just what are the data telling us about ICSI offspring health and future fertility and should we be concerned?
Hum. Reprod.,
May 1, 2003;
18(5):
925 - 931.
[Abstract][Full Text][PDF]
L. Frydelund-Larsen, C. Krausz, H. Leffers, A. M. Andersson, E. Carlsen, S. Bangsboell, K. Mcelreavey, N. E. Skakkebaek, and E. Rajpert-De Meyts Inhibin B: A Marker for the Functional State of the Seminiferous Epithelium in Patients with Azoospermia Factor c Microdeletions
J. Clin. Endocrinol. Metab.,
December 1, 2002;
87(12):
5618 - 5624.
[Abstract][Full Text][PDF]
R. D. Oates, S. Silber, L. G. Brown, and D. C. Page Clinical characterization of 42 oligospermic or azoospermic men with microdeletion of the AZFc region of the Y chromosome, and of 18 children conceived via ICSI
Hum. Reprod.,
November 1, 2002;
17(11):
2813 - 2824.
[Abstract][Full Text][PDF]
C.M. Luetjens, J. Gromoll, M. Engelhardt, S. von Eckardstein, M. Bergmann, E. Nieschlag, and M. Simoni Manifestation of Y-chromosomal deletions in the human testis: a morphometrical and immunohistochemical evaluation
Hum. Reprod.,
September 1, 2002;
17(9):
2258 - 2266.
[Abstract][Full Text][PDF]
L C Layman Human gene mutations causing infertility
J. Med. Genet.,
March 1, 2002;
39(3):
153 - 161.
[Abstract][Full Text][PDF]
C. Krausz, L. Quintana-Murci, E. R.-D. Meyts, N. Jorgensen, M.A. Jobling, Z.H. Rosser, N.E. Skakkebaek, and K. McElreavey Identification of a Y chromosome haplogroup associated with reduced sperm counts
Hum. Mol. Genet.,
September 1, 2001;
10(18):
1873 - 1877.
[Abstract][Full Text][PDF]